Anti-angiogenic and antitumor activities of Huaier aqueous extract

Oncology Reports

Volumn 28, Issue 4, 2012, Pages 1167-1175

  Wang, Xiaolong ^a   Zhang, Ning ^a   Huo, Qiang ^a   Yang, Qifeng ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

4T1; Angiogenesis; Huaier; Human umbilical vein endothelial cell; Tumor

Indexed keywords

ANTINEOPLASTIC AGENT; MITOGEN ACTIVATED PROTEIN KINASE; PLANT EXTRACT; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRAMELES ROBINIOPHILA EXTRACT; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL MOTILITY; CHORIOALLANTOIS; DRUG MECHANISM; EMBRYO; ENZYME PHOSPHORYLATION; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRAMETES; TRAMETES ROBINIOPHILA; TUMOR GROWTH; TUMOR XENOGRAFT; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL MOVEMENT; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; ENDOTHELIUM, VASCULAR; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MEDICINE, CHINESE TRADITIONAL; MICE; MICE, INBRED BALB C; PLANT EXTRACTS; SIGNAL TRANSDUCTION; TRAMETES; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84866452268     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1961     Document Type: Article

References (47)

1. WHO: Cancer. http://www.who.int/mediacentre/factsheets/fs297/en/index. html, 2012.
2. DeSantis C, Siegel R, Bandi P and Jemal A: Breast cancer statistics, 2011. CA Cancer J Clin 61: 409-418, 2011.
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
4. IARC: Cancer Epidemiology Database. GLOBOCAN 2002.
5. IARC: Cancer Epidemiology Database. GLOBOCAN 2008.
6. Monsuez JJ, Charniot JC, Vignat N and Artigou JY: Cardiac side-effects of cancer chemotherapy. Int J Cardiol 144: 3-15, 2010.
7. Bhat TA and Singh RP: Tumor angiogenesis - a potential target in cancer chemoprevention. Food Chem Toxicol 46: 1334-1345, 2008. (Pubitemid 351258200)
8. Sagar SM, Yance D and Wong R: Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer - Part 1. Curr Oncol 13: 14-26, 2006.
9. Risau W: Mechanisms of angiogenesis. Nature 386: 671-674, 1997.
10. Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407: 249-257, 2000.
11. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31, 1995.
12. Hanahan D and Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364, 1996. (Pubitemid 26272076)
13. Tassi E and Wellstein A: Tumor angiogenesis: initiation and targeting - therapeutic targeting of an FGF-binding protein, an angiogenic switch molecule, and indicator of early stages of gastrointestinal adenocarcinomas. Cancer Res Treat 38: 189-197, 2006.
14. Weidner N, Carroll P, Flax J, Blumenfeld W and Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143: 401-409, 1993. (Pubitemid 24058195)
15. Maeda K, Chung YS, Takatsuka S, et al: Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 13: 477-481, 1995.
16. Choi HJ, Hyun MS, Jung GJ, Kim SS and Hong SH: Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence. Oncology 55: 575-581, 1998. (Pubitemid 28479118)
17. Frank RE, Saclarides TJ, Leurgans S, Speziale NJ, Drab EA and Rubin DB: Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer. Ann Surg 222: 695-699, 1995. (Pubitemid 26001232)
18. Folkman J and Cotran R: Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol 16: 207-248, 1976.
19. Weidner N, Semple JP, Welch WR and Folkman J: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
20. Keshavarz M, Mostafaie A, Mansouri K, Bidmeshkipour A, Motlagh HR and Parvaneh S: In vitro and ex vivo antiangiogenic activity of Salvia officinalis. Phytother Res 24: 1526-1531, 2010.
21. Lu J, Zhang K, Nam S, Anderson RA, Jove R and Wen W: Novel angiogenesis inhibitory activity in cinnamon extract blocks VEGFR2 kinase and downstream signaling. Carcinogenesis 31: 481-488, 2010.
22. Nassar ZD, Aisha AF, Ahamed MB, et al: Antiangiogenic properties of Koetjapic acid, a natural triterpene isolated from Sandoricum koetjaoe Merr. Cancer Cell Int 11: 12, 2011.
23. Ren J, Zheng C, Feng G, et al: Inhibitory effect of extract of fungi of Huaier on hepatocellular carcinoma cells. J Huazhong Univ Sci Technolog Med Sci 29: 198-201, 2009.
24. Xu X, Wei Q, Wang K, et al: Anticancer effects of Huaier are associated with down-regulation of P53. Asian Pac J Cancer Prev 12: 2251-2254, 2011.
25. Zhang N, Kong X, Yan S, Yuan C and Yang Q: Huaier aqueous extract inhibits proliferation of breast cancer cells by inducing apoptosis. Cancer Sci 101: 2375-2383, 2010.
26. Liang CC, Park AY and Guan JL: In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2: 329-333, 2007. (Pubitemid 47040047)
27. Wu J, Lu Y, Gao M and Zhang W: The advances of angiogenesis assay models. Chin Pharmacol Bull 24: 11, 2008.
28. Kruger EA, Duray PH, Tsokos MG, et al: Endostatin inhibits microvessel formation in the ex vivo rat aortic ring angiogenesis assay. Biochem Biophys Res Commun 268: 183-191, 2000. (Pubitemid 30116631)
29. Patsouris D, Neels JG, Fan W, Li PP, Nguyen MT and Olefsky JM: Glucocorticoids and thiazolidinediones interfere with adipocyte-mediated macrophage chemotaxis and recruitment. J Biol Chem 284: 31223-31235, 2009.
30. Hu B, Du Q, Shen K and Xu L: Principles and scientific basis of traditional Chinese medicine in cancer treatment. J Bioanal Biomed S 6: 2, 2012.
31. Liu Y, Ling Y, Hu W, et al: The herb medicine formula 'Chong Lou Fu Fang' increases the cytotoxicity of chemotherapeutic agents and down-regulates the expression of chemotherapeutic agent resistance-related genes in human gastric cancer cells in vitro. Evid Based Complement Alternat Med 2011: 834231 2011.
32. Ostermann T, Raak C and Bussing A: Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review. BMC Cancer 9: 451, 2009.
33. Abdollahi A, Lipson KE, Sckell A, et al: Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects. Cancer Res 63: 8890-8898, 2003. (Pubitemid 38064069)
34. Folkman J, Hahnfeldt P and Hlatky L: The logic of anti-angiogenic gene therapy. Cold Spring Harbor Monograph Archive 36: 527-543, 1999.
35. Kamba T and McDonald DM: Mechanisms of adverse effects of anti-VEGF therapy for cancer. Br J Cancer 96: 1788-1795, 2007. (Pubitemid 46912024)
36. Wen W, Lu J, Zhang K and Chen S: Grape seed extract inhibits angiogenesis via suppression of the vascular endothelial growth factor receptor signaling pathway. Cancer Prev Res 1: 554-561, 2008.
37. Wang SJ, Sun B, Cheng ZX, et al: Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-kappaB pathway. Cancer Chemother Pharmacol 68: 1421-1430, 2011.
38. Brugarolas J, Moberg K, Boyd SD, Taya Y, Jacks T and Lees JA: Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after γ-irradiation. Proc Natl Acad Sci USA 96: 1002-1007, 1999. (Pubitemid 29072173)
39. Neufeld G, Cohen T, Gengrinovitch S and Poltorak Z: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13: 9-22, 1999. (Pubitemid 29038270)
40. Paley PJ, Staskus KA, Gebhard K, et al: Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer 80: 98-106, 1997. (Pubitemid 27270925)
41. Yang XM, Wang YS, Zhang J, et al: Role of PI3K/Akt and MEK/ERK in mediating hypoxia-induced expression of HIF-1alpha and VEGF in laser-induced rat choroidal neovascularization. Invest Ophthalmol Vis Sci 50: 1873-1879, 2009.
42. Richard DE, Berra E, Gothie E, Roux D and Pouyssegur J: p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J Biol Chem 274: 32631-32637, 1999. (Pubitemid 129535289)
43. Wang FS, Wang CJ, Chen YJ, et al: Ras induction of superoxide activates ERK-dependent angiogenic transcription factor HIF-1alpha and VEGF-A expression in shock wave-stimulated osteoblasts. J Biol Chem 279: 10331-10337, 2004.
44. Kunimasa K, Ahn MR, Kobayashi T, et al: Brazilian propolis suppresses angiogenesis by inducing apoptosis in tube-forming endothelial cells through inactivation of survival signal ERK1/2. Evid Based Complement Alternat Med 2011: 870753, 2011.
45. Huang C, Rajfur Z, Borchers C, Schaller MD and Jacobson K: JNK phosphorylates paxillin and regulates cell migration. Nature 424: 219-223, 2003. (Pubitemid 36858692)
46. Yahata Y, Shirakata Y, Tokumaru S, et al: Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation. J Biol Chem 278: 40026-40031, 2003. (Pubitemid 37248568)
47. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D and Maniatis T: Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 9: 899-909, 1995.